Inventor · disambiguated record
Bernard Haendler
Also filed as: HAENDLER BERNARD · HAENDLER BERNARD JACQUES
9 granted patents·12 pending applications·75 citations·filing 1993–2023
86Inventor score
Top patents by PatentIndex Score
21 records- 0170US6780594B2Method for in vitro diagnosis of endometriosisSCHERING AG·Filed 2001·Granted Aug 24, 2004·17 cites·11 claims
- 0258US2025319216A1Radiopharmceutical complexes targeting prostate-specific membrane antigen and its combinationsBAYER AG·Filed 2023·Application pending·0 cites
- 0356US5882887AProcess for manufacture of a modified collagen-induced platelet aggregation inhibitor pallidipinSCHERING AG·Filed 1995·Granted Mar 16, 1999·15 cites·17 claims
- 0454US6825329B2Human PEM as a target for birth control and treatment of Alzheimer's diseaseSCHERING AG·Filed 2001·Granted Nov 30, 2004·1 cites·6 claims
- 0554US6008019APlasminogen activator from saliva of the vampire batSCHERING AG·Filed 1995·Granted Dec 28, 1999·21 cites·15 claims
- 0653US5723312ACollagen-induced platelet aggregation inhibitorSCHERING AG·Filed 1995·Granted Mar 3, 1998·8 cites·20 claims
- 0752US2021369724A1Combination of atr kinase inhibitors with 2,3-dihydroimidazo[1,2-c]quinazoline compoundsBAYER AG·Filed 2019·Application pending·0 cites
- 0850US11185549B2Combination of a PI3K-inhibitor with an androgen receptor antagonistBAYER CONSUMER CARE AG·Filed 2018·Granted Nov 30, 2021·0 cites·8 claims
- 0945US2022118123A1Combination of ar antagonists and targeted thorium conjugatesBAYER AG·Filed 2020·Application pending·0 cites
- 1043US2016272635A1Substituted dihydropyrido[3,4-b]pyrazinones as dual inhibitors of bet proteins and polo-like kinasesBayer Pharma AG·Filed 2014·Application pending·0 cites
- 1142US2016009725A1Pyrrolo- and pyrazolo-triazolodiazepines as bet-protein inhibitors for treating hyperproliferative diseasesBayer Pharma AG·Filed 2014·Application pending·0 cites
- 1242US2015376196A14-substituted pyrrolo- and pyrazolo-diazepinesBayer Pharma AG·Filed 2014·Application pending·0 cites
- 1341US5756454ACollagen-induced platelet aggregation inhibitorSCHERING AG·Filed 1994·Granted May 26, 1998·6 cites·30 claims
- 1439US9663523B2BET protein-inhibiting 5-aryltriazoleazepinesBayer Pharma AG·Filed 2013·Granted May 30, 2017·0 cites·10 claims
- 1538US2016129011A1Bicyclo 2,3-benzodiazepines and spirocyclically substituted 2,3-benzodiazepinesBayer Pharma AG·Filed 2014·Application pending·0 cites
- 1638US2002165381A1Human androgen receptor variantsFiled 2001·Application pending·0 cites
- 1737US2014213575A16H-Thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepinesSCHMEES NORBERT·Filed 2012·Application pending·0 cites
- 1835US2018164317A1Method for stratification of melanoma patients by determination of oxygen consumption, ppargc1a, ppargc1b and mitf levelsBayer Pharma AG·Filed 2016·Application pending·0 cites
- 1934US5876971AThrombin inhibitor from the saliva of protostomiaSCHERING AG·Filed 1993·Granted Mar 2, 1999·7 cites·29 claims
- 2028US2017121322A1Bet-protein inhibiting 3,4-dihydropyrido[2,3-b]pyrazinones with meta-substituted aromatic amino- or ether groupsBayer Pharma AG·Filed 2015·Application pending·0 cites
- 2123US2012251551A1Substituted (Heteroarylmethyl)thiohydantoinsLUECKING ULRICH·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Bernard Haendler files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →